Advertisement

Topics

Lantern Pharma Inc. Company Profile

06:41 EDT 23rd September 2018 | BioPortfolio

Lantern Pharma is a biotech company aiming to re-invent the cancer drug development process by tailoring promising drug programs to the right cancer patients through biomarker discovery. Lantern leverages advanced genomics and machine learning based artificial intelligence (AI) to identify and significantly reduce the cost and overall risk profile of new therapies compared to traditional drug development. Lantern currently has three clinical stage candidates in its pipeline: Tavocept®, a phase 2 clinical candidate; LP-184, currently being prepared for biomarker based clinical trials; and Irofulven-1, which has been licensed out to a later stage pharma company focused for further development. For additional information on the company, please visit its website at www.lanternpharma.com.


News Articles [550 Associated News Articles listed on BioPortfolio]

Bonti starts dosing in LANTERN-2 trial of EB-001T

Bonti has commenced dosing in its LANTERN-2 clinical trial, a Phase II study designed to evaluate the safety and efficacy...Read More... The post Bonti starts dosing in LANTERN-2 trial of EB-001T appe...

Experience 1,200 Year Old Lantern Festival to Celebrate Buddha's Birthday in Seoul, the Capital ...

One of the highlights of this 1,200 yearold festival is the Lantern Parade .It will begin at 7p.m.on May 12, 2018, Read more...

Precision Oncology Company Lantern Pharma to Showcase Artificial Intelligence Approach

Lantern Pharma is applying Artificial Intelligence (AI) to tailor multiple promising precision drug programs to the right cancer patients through use of their RADRTM platform (Res...

TiE Announces AI Driven Lantern Pharma as 2018 Top 50 Emerging Company

Lantern Pharma is excited to announce that it has been selected as a "2018 TiE50 winner" for the prestigious TiE50 Awards Program recognizing the world's most innovative tech sta...

TiE Inflect 2018 Announces Lantern Pharma as a 2018 TiE50 Finalist

Lantern Pharma is excited to announce that it has been selected as a "2018 TiE50 Finalist" for the prestigious TiE50 Awards Program recognizing the world's most innovative tech st...

Lantern, a mental health startup, is shutting down its operations

The San Francisco company is folding its commercial operations on August 1 after a few acquisition deals fell through, according to TechCrunch.

Lantern Pharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 12032018] Prices from USD $250

SummaryLantern Pharma Inc Lantern Pharma is a drug development company that discovers and develops therapies for various cancer types. The company's pipeline products include Irofulven1, an antitumor ...

Lantern Pharma Inc Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 17042018] Prices from USD $250

SummaryLantern Pharma Inc Lantern Pharma is a drug development company that discovers and develops therapies for various cancer types. The company's pipeline products include Irofulven1, an antitumor ...

PubMed Articles [27 Associated PubMed Articles listed on BioPortfolio]

Improving the quality of life of aged care residents through the joy of food: The Lantern Project.

Mealtimes directly impact the quality of life of residents in aged care. The objective of The Lantern Project is to improve the dining experience of aged care residents to reduce malnutrition risk thr...

Optical trapping and micromanipulation with a photonic lantern-mode multiplexer.

We demonstrate a simple approach based on a photonic lantern spatial-mode multiplexer and a few-mode fiber for optical and manipulation of multiple microspheres. Selective generation of linearly polar...

Off-label prescription: Experience is a gloomy lantern that does not even illuminate its bearer.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Data and Corporate Governance in Pharma and Digital Health: A Necessary Regulatory Convergence.

Clinical trials go virtual, big pharma dives in.

Clinical Trials [83 Associated Clinical Trials listed on BioPortfolio]

Rivastigmine Bioequivalence Trial With Multiple Application of Transdermal Patches (9.5mg/24h)

The present clinical trial will be conducted in order to compare the bioavailability of rivastigmine and to assess bioequivalence at steady-state of the Test product RID-TDS 9.5 mg/24 h (L...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Steady State Global Bioequivalence Study of Amphotericin B Liposome for Injection 50 mg/ Vial in Fed Condition

The primary objective is to determine clinical bioequivalence of Amphotericin B liposome for injection of Auromedics Pharma LLC, USA and AmBisome (Amphotericin B) liposome for injection of...

Companies [763 Associated Companies listed on BioPortfolio]

Lantern Pharma Inc.

Lantern Pharma is a biotech company aiming to re-invent the cancer drug development process by tailoring promising drug programs to the right cancer patients through biomarker dis...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

LEO Pharma Inc.

LEO Pharma Inc. is headquartered in Parsippany, New Jersey, and is the U.S. affiliate of Denmark-based LEO Pharma A/S, a global leader in dermatology and critical care with more t...

Laurantis Pharma Oy

Laurantis Pharma Oy is a privately held specialty pharmaceutical company based in Finland. Laurantis Pharma Oy was formed in 2010 through the merger of two independent companies, ...

FranceMed Pharma

FranceMed Pharma is a Research, Development, FMCG Manufacturer and Global Marketing Company established since 1981. FranceMed Pharma owns Magicool® brand and the world-wide patents and technology. Fr...

More Information about "Lantern Pharma Inc." on BioPortfolio

We have published hundreds of Lantern Pharma Inc. news stories on BioPortfolio along with dozens of Lantern Pharma Inc. Clinical Trials and PubMed Articles about Lantern Pharma Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Lantern Pharma Inc. Companies in our database. You can also find out about relevant Lantern Pharma Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...


Corporate Database Quicklinks



Searches Linking to this Company Record